Il-yang Makes Licensing Agreement for Grupo Uriach's Rupafin

Published: 2005-04-11 06:57:00

Updated: 2005-04-11 06:57:00

Il-yang Pharmaceutical Co. announced last week that the company signed an exclusive domestic licensing agreement for Rupafin (rupatadine fumarate), a novel antihistamine agent for the management of diseases with allergic inflammatory conditions, such as seasonal and perennial rhinitis.

Developed by Grupo Uriach, one of leading pharmaceutical company in Spain, the company explained that the p...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.